Titlebook: Innovation in Vaccinology; from design, through Selene Baschieri Book 2012 Springer Science+Business Media Dordrecht 2012 Biotechnology.Imm

Visual-Acuity

Virus-Like Particles as Efficient Delivery Platform to Induce a Potent Immune Responsenst . and ., this vaccination strategy has proven its viability in the vaccines market. This chapter focuses on the different strategies existing for developing VLP vaccines, gives an overview of the VLP vaccine candidates currently clinically tested, thereby highlighting the successes and risks lin

ELUC

Provenance

Conduit

TLR Agonists as Vaccine Adjuvants of TLRs results in stimulation of antigen presenting cells and enhanced B cell and T cell activation, TLR agonists are considered promising vaccine adjuvant candidates. This chapter will focus on TLR agonists that are in development for use as vaccine adjuvants.

委派

Mucosal Vaccines for Enteric Bacterial Pathogensctive strategy which opened a new area of exploration. The development of vaccine against enteric pathogens is a challenging opportunity because a large number of bacterial pathogens exploit mucosal surface to penetrate and survive into the host. This chapter is aiming to make an overview of the pro

Occipital-Lobe

Book 2012n is the multidisciplinary teamwork. Most of the enabling technologies have been established by putting in the “melting pot” expertise in fields that, at first glance, may appear very far apart. I hope that this collection of articles will make the readers aware that vaccinology is rapidly taking a

arabesque

accomplishment

Silvia Loureiro,Elena Robinson,Hongying Chen,Pongsathon Phapugrangkul,Camilo Colaco,Ian M Jonesty. While the case studies address bothinternational and intranational concerns in specific regions of theworld, they portray broad principles that are applicab978-1-4613-7803-7978-1-4615-6117-0Series ISSN 0929-127X Series E-ISSN 2511-8560

entrance

最小